b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">\n        <PMID Version="1">29701030</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>01</Month>\n            <Day>24</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>01</Month>\n            <Day>24</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1872-2075</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>34</Volume>\n                    <Issue>4</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Apr</Month>\n                        <Day>25</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Sheng wu gong cheng xue bao = Chinese journal of biotechnology</Title>\n                <ISOAbbreviation>Sheng Wu Gong Cheng Xue Bao</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>[Preparation of anti-hCG single domain antibody by antibody grafting technique using an antigen-binding peptide].</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>569-577</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.13345/j.cjb.170372</ELocationID>\n            <Abstract>\n                <AbstractText>We used the antibody grafting technology to prepare anti-hCG single-domain antibodies on the basis of antigen-binding peptide to simplify the single-domain antibody preparation process and improving the biochemical stability of peptide. By using a universal single-domain antibody backbone (cAbBCII10), CDR1 or CDR3 was replaced by the hCG-binding peptide, and the grafted antibody gene sequences were synthesized and cloned into the prokaryotic expression vector pET30a(+) in fusion with a C-terminal sfGFP gene, i.e. pET30a-(His6)-cAbBCII10-CDR1/hCGBP1-sfGFP and pET30a-(His6)-cAbBCII10-CDR3/hCGBP3-sfGFP. The recombinant plasmids were transformed into E. coli BL21(DE3), and the fusion proteins were induced by IPTG. Highly soluble recombinant fusion proteins were obtained and purified by Ni-NTA affinity column. SDS-PAGE confirmed the purified protein as the target protein. The antigen-antibody binding assay showed that both the CDR1 and CDR3 grafted antibodies have hCG-binding activities. While the titers of the two grafted antibodies were similar, the binding affinity of CDR3 grafted antibody was higher than that of CDR1 grafted protein (about 2-3 times). The grafted antibodies retained the relatively high biochemical stability of the single-domain antibody backbone and were relatively thermostable and alkaline tolerant. The obtained antibodies also had a relatively high antigen-binding specificity to hCG. This study provided a reliable experimental basis for further optimization of anti-hCG single domain antibody by antibody grafting technology using antigen-binding peptide.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Peng</LastName>\n                    <ForeName>Jing</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>College of Life Science and Health, Wuhan University of Science and Technology, Wuhan 430065, Hubei, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Qiong</ForeName>\n                    <Initials>Q</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>College of Life Science and Health, Wuhan University of Science and Technology, Wuhan 430065, Hubei, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cheng</LastName>\n                    <ForeName>Xiaoling</ForeName>\n                    <Initials>X</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>College of Life Science and Health, Wuhan University of Science and Technology, Wuhan 430065, Hubei, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Liu</LastName>\n                    <ForeName>Mengwen</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>College of Life Science and Health, Wuhan University of Science and Technology, Wuhan 430065, Hubei, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Mei</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>College of Life Science and Health, Wuhan University of Science and Technology, Wuhan 430065, Hubei, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Xin</LastName>\n                    <ForeName>Huawei</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>College of Life Science and Health, Wuhan University of Science and Technology, Wuhan 430065, Hubei, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>chi</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>China</Country>\n            <MedlineTA>Sheng Wu Gong Cheng Xue Bao</MedlineTA>\n            <NlmUniqueID>9426463</NlmUniqueID>\n            <ISSNLinking>1000-3061</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D006063">Chorionic Gonadotropin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D022801">Complementarity Determining Regions</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D010455">Peptides</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D061905">Single-Domain Antibodies</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000918" MajorTopicYN="N">Antibody Specificity</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006063" MajorTopicYN="N">Chorionic Gonadotropin</DescriptorName>\n                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D022801" MajorTopicYN="N">Complementarity Determining Regions</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName>\n                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D061905" MajorTopicYN="N">Single-Domain Antibodies</DescriptorName>\n                <QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <OtherAbstract Type="Publisher" Language="chi">\n            <AbstractText>\xe6\x9c\xac\xe7\xa0\x94\xe7\xa9\xb6\xe6\x97\xa8\xe5\x9c\xa8\xe4\xba\xba\xe7\xbb\x92\xe6\xaf\x9b\xe8\x86\x9c\xe4\xbf\x83\xe6\x80\xa7\xe8\x85\xba\xe6\xbf\x80\xe7\xb4\xa0 (hCG) \xe7\x9a\x84\xe7\xbb\x93\xe5\x90\x88\xe5\xa4\x9a\xe8\x82\xbd\xe7\x9a\x84\xe5\x9f\xba\xe7\xa1\x80\xe4\xb8\x8a\xe5\xba\x94\xe7\x94\xa8\xe5\xab\x81\xe6\x8e\xa5\xe6\x8a\x97\xe4\xbd\x93\xe6\x8a\x80\xe6\x9c\xaf\xe5\x88\xb6\xe5\xa4\x87\xe6\x8a\x97hCG \xe5\x8d\x95\xe5\x9f\x9f\xe6\x8a\x97\xe4\xbd\x93\xef\xbc\x8c\xe7\xae\x80\xe5\x8c\x96\xe5\x8d\x95\xe5\x9f\x9f\xe6\x8a\x97\xe4\xbd\x93\xe5\x88\xb6\xe5\xa4\x87\xe8\xbf\x87\xe7\xa8\x8b\xef\xbc\x8c\xe6\x8f\x90\xe9\xab\x98\xe5\xa4\x9a\xe8\x82\xbd\xe7\x94\x9f\xe5\x8c\x96\xe7\xa8\xb3\xe5\xae\x9a\xe6\x80\xa7\xe3\x80\x82\xe5\x88\xa9\xe7\x94\xa8\xe5\x8d\x95\xe5\x9f\x9f\xe6\x8a\x97\xe4\xbd\x93\xe9\x80\x9a\xe7\x94\xa8\xe9\xaa\xa8\xe6\x9e\xb6 (cAbBCII10)\xef\xbc\x8c\xe4\xbb\xa5hCG \xe7\xbb\x93\xe5\x90\x88\xe5\xa4\x9a\xe8\x82\xbd\xe5\x8f\x96\xe4\xbb\xa3\xe4\xba\x92\xe8\xa1\xa5\xe5\x86\xb3\xe5\xae\x9a\xe5\x8c\xbaCDR1 \xe6\x88\x96CDR3\xef\xbc\x8c\xe5\x90\x88\xe6\x88\x90cAbBCII10 \xe5\xab\x81\xe6\x8e\xa5\xe6\x8a\x97\xe4\xbd\x93\xe5\x85\xa8\xe5\x9f\xba\xe5\x9b\xa0\xe5\xba\x8f\xe5\x88\x97\xe5\xb9\xb6\xe4\xb8\x8esfGFP \xe5\x9f\xba\xe5\x9b\xa0\xe5\xba\x8f\xe5\x88\x97\xe8\x9e\x8d\xe5\x90\x88\xe5\x90\x8e\xef\xbc\x8c\xe6\x8f\x92\xe5\x85\xa5\xe5\x88\xb0\xe5\xb8\xa6\xe6\x9c\x89His \xe6\xa0\x87\xe7\xad\xbe\xe7\x9a\x84\xe5\x8e\x9f\xe6\xa0\xb8\xe8\xa1\xa8\xe8\xbe\xbe\xe8\xbd\xbd\xe4\xbd\x93pET30a(+) \xe4\xb8\xad\xef\xbc\x8c\xe6\x88\x90\xe5\x8a\x9f\xe6\x9e\x84\xe5\xbb\xba\xe4\xba\x86pET30a-(His6)-cAbBCII10-CDR1/hCGBP1-sfGFP \xe4\xb8\x8epET30a-(His6)-cAbBCII10-CDR3/hCGBP3-sfGFP \xe8\x9e\x8d\xe5\x90\x88\xe8\x9b\x8b\xe7\x99\xbd\xe8\xa1\xa8\xe8\xbe\xbe\xe8\xb4\xa8\xe7\xb2\x92\xe3\x80\x82\xe5\xb0\x86\xe9\x87\x8d\xe7\xbb\x84\xe8\xb4\xa8\xe7\xb2\x92\xe8\xbd\xac\xe5\x8c\x96\xe5\xa4\xa7\xe8\x82\xa0\xe6\x9d\x86\xe8\x8f\x8cBL21 (DE3)\xef\xbc\x8c\xe7\x94\xa8IPTG \xe8\xaf\xb1\xe5\xaf\xbc\xe8\xa1\xa8\xe8\xbe\xbe\xe8\x9e\x8d\xe5\x90\x88\xe8\x9b\x8b\xe7\x99\xbd\xef\xbc\x8c\xe5\xbe\x97\xe5\x88\xb0\xe9\xab\x98\xe8\xa1\xa8\xe8\xbe\xbe\xe9\x87\x8f\xe7\x9a\x84\xe5\x8f\xaf\xe6\xba\xb6\xe6\x80\xa7\xe8\x9e\x8d\xe5\x90\x88\xe8\x9b\x8b\xe7\x99\xbd\xe3\x80\x82\xe5\x88\xa9\xe7\x94\xa8Ni-NTA \xe4\xba\xb2\xe5\x92\x8c\xe6\x9f\xb1\xe7\xba\xaf\xe5\x8c\x96\xe5\xbe\x97\xe5\x88\xb0\xe7\xba\xaf\xe8\x9b\x8b\xe7\x99\xbd\xef\xbc\x8c\xe5\xba\x94\xe7\x94\xa8SDS-PAGE \xe9\x89\xb4\xe5\xae\x9a\xe7\xba\xaf\xe5\x8c\x96\xe7\x9a\x84\xe8\x9b\x8b\xe7\x99\xbd\xe4\xb8\xba\xe6\xad\xa3\xe7\xa1\xae\xe8\xa1\xa8\xe8\xbe\xbe\xe7\x9a\x84\xe7\x9b\xae\xe6\xa0\x87\xe8\x9b\x8b\xe7\x99\xbd\xe3\x80\x82\xe9\x80\x9a\xe8\xbf\x87\xe6\x8a\x97\xe5\x8e\x9f\xe6\x8a\x97\xe4\xbd\x93\xe7\xbb\x93\xe5\x90\x88\xe5\xae\x9e\xe9\xaa\x8c\xef\xbc\x8c\xe5\x8f\x91\xe7\x8e\xb0hCG \xe7\xbb\x93\xe5\x90\x88\xe5\xa4\x9a\xe8\x82\xbd\xe5\xab\x81\xe6\x8e\xa5\xe5\x88\xb0\xe5\x8d\x95\xe5\x9f\x9f\xe6\x8a\x97\xe4\xbd\x93\xe9\x80\x9a\xe7\x94\xa8\xe9\xaa\xa8\xe6\x9e\xb6\xe7\x9a\x84\xe4\xba\x92\xe8\xa1\xa5\xe5\x86\xb3\xe5\xae\x9a\xe5\x8c\xbaCDR1 \xe6\x88\x96CDR3 \xe5\x90\x8e\xe9\x83\xbd\xe6\x9c\x89\xe6\x8a\x97\xe5\x8e\x9f\xe7\xbb\x93\xe5\x90\x88\xe6\xb4\xbb\xe6\x80\xa7\xef\xbc\x8c\xe5\x85\xb7\xe6\x9c\x89\xe7\x9b\xb8\xe4\xbc\xbc\xe7\x9a\x84\xe6\x8a\x97\xe4\xbd\x93\xe6\xbb\xb4\xe5\xba\xa6\xef\xbc\x8c\xe4\xb8\x94\xe5\xab\x81\xe6\x8e\xa5\xe5\x88\xb0CDR3 \xe5\x90\x8e\xe7\x9a\x84\xe6\x8a\x97\xe5\x8e\x9f\xe7\xbb\x93\xe5\x90\x88\xe6\xb4\xbb\xe6\x80\xa7\xe6\xaf\x94CDR1 \xe8\xa6\x81\xe9\xab\x98(2\xe2\x80\x933 \xe5\x80\x8d)\xe3\x80\x82\xe5\xab\x81\xe6\x8e\xa5\xe6\x8a\x97\xe4\xbd\x93\xe5\x9f\xba\xe6\x9c\xac\xe4\xbf\x9d\xe7\x95\x99\xe4\xba\x86\xe6\x89\x80\xe7\x94\xa8\xe5\x8d\x95\xe5\x9f\x9f\xe6\x8a\x97\xe4\xbd\x93\xe6\xa1\x86\xe6\x9e\xb6\xe8\xbe\x83\xe4\xb8\xba\xe7\xa8\xb3\xe5\xae\x9a\xe7\x9a\x84\xe7\x94\x9f\xe5\x8c\x96\xe7\x89\xb9\xe6\x80\xa7\xef\xbc\x8c\xe5\x85\xb7\xe6\x9c\x89\xe4\xb8\x80\xe5\xae\x9a\xe7\x9a\x84\xe7\x83\xad\xe7\xa8\xb3\xe5\xae\x9a\xe6\x80\xa7\xe5\x92\x8c\xe8\xbe\x83\xe5\xa5\xbd\xe7\x9a\x84\xe7\xa2\xb1\xe8\x80\x90\xe5\x8f\x97\xe6\x80\xa7\xef\xbc\x8c\xe5\x90\x8c\xe6\x97\xb6\xef\xbc\x8c\xe6\x89\x80\xe6\x8e\xa5\xe5\x85\xa5\xe7\x9a\x84hCG \xe7\xbb\x93\xe5\x90\x88\xe7\x89\x87\xe6\xae\xb5\xe5\xaf\xb9hCG \xe5\x85\xb7\xe6\x9c\x89\xe8\xbe\x83\xe7\x89\xb9\xe5\xbc\x82\xe7\x9a\x84\xe7\xbb\x93\xe5\x90\x88\xe6\xb4\xbb\xe6\x80\xa7\xef\xbc\x8c\xe4\xb8\xba\xe8\xbf\x9b\xe4\xb8\x80\xe6\xad\xa5\xe4\xbc\x98\xe5\x8c\x96\xe6\x8a\x97\xe5\x8e\x9f\xe7\xbb\x93\xe5\x90\x88\xe5\xa4\x9a\xe8\x82\xbd\xe5\xab\x81\xe6\x8e\xa5\xe6\x8a\x97\xe4\xbd\x93\xe6\x8a\x80\xe6\x9c\xaf\xe5\x88\xb6\xe5\xa4\x87\xe6\x8a\x97hCG \xe5\x8d\x95\xe5\x9f\x9f\xe6\x8a\x97\xe4\xbd\x93\xe6\x8f\x90\xe4\xbe\x9b\xe4\xba\x86\xe5\x8f\xaf\xe9\x9d\xa0\xe7\x9a\x84\xe5\xae\x9e\xe9\xaa\x8c\xe5\x9f\xba\xe7\xa1\x80\xe3\x80\x82.</AbstractText>\n        </OtherAbstract>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">CDR1</Keyword>\n            <Keyword MajorTopicYN="N">CDR3</Keyword>\n            <Keyword MajorTopicYN="N">expression and purification</Keyword>\n            <Keyword MajorTopicYN="N">fusion protein</Keyword>\n            <Keyword MajorTopicYN="N">grafted antibody</Keyword>\n            <Keyword MajorTopicYN="N">hCG</Keyword>\n            <Keyword MajorTopicYN="N">single domain antibody</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>4</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>4</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>1</Month>\n                <Day>25</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29701030</ArticleId>\n            <ArticleId IdType="doi">10.13345/j.cjb.170372</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'